{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T20:20:12Z","timestamp":1725826812178},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T00:00:00Z","timestamp":1210723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1752-1947-2-155","type":"journal-article","created":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T14:13:49Z","timestamp":1210774429000},"source":"Crossref","is-referenced-by-count":4,"title":["Diabetic control and atypical antipsychotics: a case report"],"prefix":"10.1186","volume":"2","author":[{"given":"Romina Lopez","family":"Gaston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nangai","family":"Azhahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,14]]},"reference":[{"key":"342_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/oby.2004.46","volume":"12","author":"American Diabetes Association, American Psychiatric Association, APA, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity","year":"2004","unstructured":"American Diabetes Association, American Psychiatric Association, APA, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus development conference on antipsychotic drugs and obesity and diabetes. Obes Res. 2004, 12: 362-368.","journal-title":"Obes Res"},{"key":"342_CR2","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","volume":"321","author":"J Geddes","year":"2000","unstructured":"Geddes J, Freemantle N, Harrison P, Bebbington P: Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. Br Med J. 2000, 321: 1371-1376. 10.1136\/bmj.321.7273.1371.","journal-title":"Br Med J"},{"key":"342_CR3","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.clinthera.2004.12.003","volume":"26","author":"JW Newcomer","year":"2004","unstructured":"Newcomer JW: Metabolic risk during antipsychotic treatment. Clin Ther. 2004, 26: 1936-1946. 10.1016\/j.clinthera.2004.12.003.","journal-title":"Clin Ther"},{"issue":"11","key":"342_CR4","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.4088\/JCP.v66n1117","volume":"66","author":"MJ Sermyak","year":"2005","unstructured":"Sermyak MJ, Gulanski B, Rosenheck R: Undiagnosed hyperglycemia in patients treated with atypical antipsychotics. J Clin Psychiatry. 2005, 66 (11): 1463-1467.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 47","key":"342_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1192\/bjp.184.47.s106","volume":"184","author":"S Gough","year":"2004","unstructured":"Gough S, Peveler R: Diabetes and its prevention: pragmatic solutions for people with schizophrenia. Br J Psychiatry. 2004, 184 (Suppl 47): 106-111. 10.1192\/bjp.184.47.s106.","journal-title":"Br J Psychiatry"},{"issue":"Suppl 18","key":"342_CR6","first-page":"36","volume":"65","author":"JW Newcomer","year":"2004","unstructured":"Newcomer JW: Abnormalities of glucose metabolism associated with atypical antipsychotic drugs. J Clin Psychiatry. 2004, 65 (Suppl 18): 36-46.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 1","key":"342_CR7","first-page":"1","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW: Second generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005, 19 (Suppl 1): 1-93.","journal-title":"CNS Drugs"},{"key":"342_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.yic.0000285500.87524.5a","volume":"22","author":"E Duncan","year":"2007","unstructured":"Duncan E, Dunlop B, Boshoven W, Woolson S: Relative risk of glucose elevation during antipsychotic exposure in Veterans Administration Population. Int Clin Psychopharmacol. 2007, 22: 1-11. 10.1097\/01.yic.0000285500.87524.5a.","journal-title":"Int Clin Psychopharmacol"},{"key":"342_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/sj.npp.1301209","volume":"32","author":"K Houseknecht","year":"2007","unstructured":"Houseknecht K, Robertson A, Zavadoski W, Gibbs EM, Johnson DE, Rollema H: Acute effects of atypical antipsychotics on whole body insulin resistance in rats: implications for adverse metabolic effects. Neuropsychopharmacology. 2007, 32: 289-297. 10.1038\/sj.npp.1301209.","journal-title":"Neuropsychopharmacology"},{"key":"342_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/schbul\/sbl037","volume":"33","author":"M De Hert","year":"2007","unstructured":"De Hert M, Hanssens L, Van Winkel R, Wampers M, Van Eyck D, Sheen A, Peuskens J: A Case Series: evaluation of the metabolic safety of aripiprazole. Schizophr Bull. 2007, 33: 823-830. 10.1093\/schbul\/sbl037.","journal-title":"Schizophr Bull"},{"key":"342_CR11","first-page":"303","volume":"7","author":"S Reddymasu","year":"2006","unstructured":"Reddymasu S, Bahta E, Levine S, Manas K, Slay L: Elevated lipase and diabetic ketoacidosis associated with aripiprazole. JOP. 2006, 7: 303-305.","journal-title":"JOP"},{"key":"342_CR12","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1464-5491.2005.01628.x","volume":"22","author":"CO Church","year":"2005","unstructured":"Church CO, Stevens DL, Fugate SE: Diabetic ketoacidosis associated with aripiprazole. Diabet Med. 2005, 22: 1440-1443. 10.1111\/j.1464-5491.2005.01628.x.","journal-title":"Diabet Med"},{"key":"342_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-004-1922-7","volume":"175","author":"KI Melkersson","year":"2004","unstructured":"Melkersson KI, Dahl ML, Hulting AL: Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis metabolism. Psychopharmacology. 2004, 175: 1-6. 10.1007\/s00213-004-1922-7.","journal-title":"Psychopharmacology"},{"key":"342_CR14","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.2337\/dc-06-1393","volume":"29","author":"M De Hert","year":"2006","unstructured":"De Hert M, Hansens L, van Winkel R, Wampers M, Van Eyck D, Sheen A, Peuskens J: Reversibility of antipsychotic treatment-related diabetes in patients with schizophrenia; a case series of switching to aripiprazole. Diabetes Care. 2006, 29: 2329-2330. 10.2337\/dc-06-1393.","journal-title":"Diabetes Care"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-2-155\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-2-155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-2-155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-2-155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T15:09:27Z","timestamp":1548083367000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-2-155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,14]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["342"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-2-155","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,14]]},"article-number":"155"}}